RE:house one Hey Nortzy, I tend to agree with you, it looks like someone is determined to keep the share price at these levels. It could also be the 35 cents PP shares being sold, like another poster previously suggested. Although frustrating to look at, I believe it will turn out profitable to those who are patient enough to wait for things to unfold. Having Knight therapeutics involved financially in the company is quite reassuring to me. They must believe that 3DS technology is viable and promising.
I first got into this stock on the AD news (I was late to the party and gor my shares for 86 cents, not so proud of this...). Having worked with a group of researchers looking for ways to identify the onset/early signs of the disease, I truly believe in the value of 3DS tech (if what they claim is proven reliable). As life expectancy increases, combined with population aging, AD prevalence continues to rise. By detecting AD in its early stages, it is now possible to slow down its progression. For me, just the AD test is enough to justify the current company's market cap. Adding all the other tests makes this co. wayyyy undervalued.
JMHO, of course... GLTA, toto